Jeffrey Varnes
- Synthesis and Catalytic Reactions
- Mast cells and histamine
- Immune cells in cancer
- Cancer Research and Treatments
- Cancer, Stress, Anesthesia, and Immune Response
- Immune Cell Function and Interaction
- Inflammatory mediators and NSAID effects
- Cancer Immunotherapy and Biomarkers
- Amino Acid Enzymes and Metabolism
Abstract Antitumor immunity can be hampered by immunosuppressive mechanisms in the tumor microenvironment, including recruitment of arginase (ARG) expressing myeloid cells that deplete l-arginine essential for optimal T-cell and natural killer cell function. Hence, ARG inhibition reverse immunosuppression enhancing antitumor immunity. We describe AZD0011, a novel peptidic boronic acid prodrug to deliver an orally available, highly potent, inhibitor payload (AZD0011-PL). demonstrate...
<p>Supplementary Figure 4</p>
<p>Supplementary Figure 2</p>
<p>Supplementary Figure 3</p>
<p>Supplementary Figure 5</p>
<p>Supplementary Figure 1</p>
<div>Abstract<p>Anti-tumor immunity can be hampered by immunosuppressive mechanisms in the tumor microenvironment including recruitment of arginase (ARG) expressing myeloid cells which deplete L-arginine essential for optimal T cell and natural killer function. Hence, ARG inhibition reverse immunosuppression enhancing anti-tumor immunity. We describe AZD0011, a novel peptidic boronic acid prodrug to deliver an orally available, highly potent, inhibitor payload (AZD0011-PL)....
<p>Supplementary Figure 5</p>
<p>Supplementary Figure 4</p>
<p>Supplementary Figure 3</p>
<p>Supplementary Figure 1</p>
<p>Supplementary Figure 2</p>
<div>Abstract<p>Antitumor immunity can be hampered by immunosuppressive mechanisms in the tumor microenvironment, including recruitment of arginase (ARG) expressing myeloid cells that deplete l-arginine essential for optimal T-cell and natural killer cell function. Hence, ARG inhibition reverse immunosuppression enhancing antitumor immunity. We describe AZD0011, a novel peptidic boronic acid prodrug to deliver an orally available, highly potent, inhibitor payload (AZD0011-PL)....
<p>Supplementary Figure 1</p>
<p>Supplementary Figure 4</p>
<p>Supplementary Figure 5</p>
<p>Supplementary Figure 2</p>
<p>Supplementary Figure 2</p>
<p>Supplementary Figure 5</p>
<p>Supplementary Figure 3</p>
<p>Supplementary Figure 4</p>